Iprindole

Iobenguane I 123 is a radiopharmaceutical. Radiopharmaceuticals are radioactive agents, which may be used to find and treat certain diseases or to study the function of the body's organs. Iobenguane I 123 is used to find certain kinds of cancer of the adrenal glands (eg, pheochromocytoma, neuroblastoma). When very small doses of iobenguane I 123 are given, the radioactivity taken up by the adrenal gland helps find tumors of the adrenal glands. An image of the gland on film or on a computer screen can be provided to help with the diagnosis. Iobenguane I 123 is also used during a test for patients with congestive heart failure. This may help the doctor see certain heart problems. This medicine is to be given only by or under the direct supervision of a doctor with specialized training in nuclear medicine.

Iobenguane I 123 is a radiopharmaceutical. Radiopharmaceuticals are radioactive agents, which may be used to find and treat certain diseases or to study the function of the body's organs. Iobenguane I 123 is used to find certain kinds of cancer of the adrenal glands (eg, pheochromocytoma, neuroblastoma). When very small doses of iobenguane I 123 are given, the radioactivity taken up by the adrenal gland helps find tumors of the adrenal glands. An image of the gland on film or on a computer screen can be provided to help with the diagnosis. Iobenguane I 123 is also used during a test for patients with congestive heart failure. This may help the doctor see certain heart problems. This medicine is to be given only by or under the direct supervision of a doctor with specialized training in nuclear medicine.

Iprindole is contraindicated in conditions like Mania.

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Check with your doctor or nurse immediately if any of the following side effects occur: Incidence not known Difficulty breathing or swallowing fast heartbeat fever hives hoarseness irritation itching joint pain, stiffness, or swelling nausea rash reddening of the skin, especially around the ears swelling of the eyes, face, or inside of the nose tightness in the chest unusual tiredness or weakness Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them: Less common Bleeding, blistering, bruising, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site dizziness feeling of warmth or redness of the face, neck, arms, and occasionally, upper chest Rare Headache Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

IPRINDOLE posesses antimuscarinic activity so care should be taken in glaucoma and prostatic enlargement. Prolonged seizures have occurred following concurrent ECT. Avoid abrupt withdrawal. Withdraw IPRINDOLE gradually over several weeks. Caution in patients taking Monoamine Oxidase Inhibiting antidepressants (MAOI). IPRINDOLE may cause hypertensive crisis.

Drug should not be given to Pregnant Mothers, patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

No adult dosage information is recorded for this medicine yet.

No child dosage information is recorded for this medicine yet.

No neonatal dosage information is recorded for this medicine yet.

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this diagnostic test, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive. Receiving this diagnostic test with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Albuterol Amineptine Amitriptyline Amitriptylinoxide Amoxapine Bambuterol Bupropion Butriptyline Carvedilol Citalopram Clomipramine Cocaine Desipramine Desvenlafaxine Dibenzepin Dothiepin Doxepin Duloxetine Ephedrine Epinephrine Escitalopram Fluoxetine Fluvoxamine Furazolidone Guanethidine Imipramine Iprindole Iproniazid Isocarboxazid Isoproterenol Labetalol Linezolid Lofepramine Melitracen Metaproterenol Methylene Blue Metyrosine Midodrine Milnacipran Moclobemide Nefazodone Norepinephrine Nortriptyline Opipramol Pargyline Paroxetine Phenelzine Phenylephrine Phenylpropanolamine Procarbazine Propizepine Protriptyline Pseudoephedrine Rasagiline Reserpine Selegiline Sertraline Terbutaline Tianeptine Tranylcypromine Trimipramine Venlafaxine

No storage information is recorded for this medicine yet.